Each three seconds somebody across the globe develops some type of dementia – the seventh main reason behind dying worldwide, in keeping with the World Well being Group.
And over 50 million individuals are at the moment affected by dementia – a quantity that may exceed 100 million within the subsequent twenty years.
That is what Constantinos Lyketsos, the Professor heading the Alzheimer’s Illness Analysis within the Division of Psychiatry and Behavioral Sciences on the Johns Hopkins College in Baltimore, USA, advised Phileleftheros in an interview.
Greece-born Lyketsos can also be the founding director of the Richman Household Precision Drugs Heart of Excellence in Alzheimer’s Illness, and an affiliate director of the Johns Hopkins Alzheimer’s Illness Analysis Heart.
He additionally stated that Alzheimer’s illness is just not a single one – as most individuals suppose. It has greater than ten completely different varieties, truly.
“The truth that we don’t but have a treatment is as a result of we deal with it as an entity and we’ve got the identical treatment for everybody, whereas the wants of every one who suffers from it are completely different,” he additionally stated.
Sooner or later, when we’ve got the suitable means “medical precision” strategies might need to be utilized, the place every affected person can have individualized care and remedy,” he added.
The essential thought is that the fitting remedy is given to the fitting affected person, on the proper time – one thing that may assist them cope with such a troublesome and complicated illness extra successfully.
The treatment for the illness for the time being doesn’t exist nor does it seem on the horizon – a minimum of not for the following fifteen years, he stated.